Theratechnologies Files 6-K, Announces Press Release
| Field | Detail |
|---|---|
| Company | Theratechnologies Inc. |
| Form Type | 6-K |
| Filed Date | Jul 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, press-release
Related Tickers: THTX
TL;DR
Theratechnologies dropped a 6-K on July 9th, likely with news. Check the press release.
AI Summary
Theratechnologies Inc. filed a Form 6-K on July 9, 2025, to report a press release dated July 9, 2025. The filing does not contain specific financial figures or operational updates beyond the announcement of the press release itself.
Why It Matters
This filing indicates Theratechnologies Inc. is providing an update to the market, likely containing material information that investors should review.
Risk Assessment
Risk Level: low — The filing is a routine report of a press release and does not contain new financial or operational risks.
Key Players & Entities
- Theratechnologies Inc. (company) — Filer of the 6-K report
- July 9, 2025 (date) — Date of the press release and filing
- Philippe Dubuc (person) — Senior Vice President and Chief Financial Officer signing the report
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report a press release dated July 9, 2025, as required for foreign private issuers.
What is the filing date of this report?
This report was filed on July 9, 2025.
Who signed this report on behalf of Theratechnologies Inc.?
Philippe Dubuc, Senior Vice President and Chief Financial Officer, signed the report.
What is the principal executive office address for Theratechnologies Inc.?
The principal executive office is located at 2015 Peel Street, Suite 1100, Montreal, Quebec H3A 1T8, Canada.
Does this filing include an annual report?
No, this filing is a Form 6-K, which is a report of foreign private issuers. The company indicates it files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 9, 2025 by Philippe Dubuc regarding Theratechnologies Inc..